Glycemic Improvement With Team, Technology, Education and Peer Resources in Type 1 Diabetes-GLITTER Study

Recruiting now · Not applicable

Conditions studied: Type 1 Diabetes (T1D)

In brief

The GLITTER study is comprised of four key components: Team, Technology, Education, and Peer Resources. The aim of the GLITTER Study is to improve the metabolic control rate in patients with type 1 diabetes through a comprehensive management approach.

Key facts

Study ID

NCT07097805

Run by

Second Xiangya Hospital of Central South University

People needed

3000

Starts

2025-01-01

Expected to finish

2028-03-01

Last updated by the study team

2025-07-31

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with type 1 diabetes of all age groups, regardless of disease duration.
• The diagnosis criteria for type 1 diabetes are met by fulfilling any one point from the first two criteria plus any one point from the third criterion.
• Clinically diagnosed as Type 1 Diabetes by a specialist physician.
• Meet any one of the following criteria:
• A. Age of onset <15 years B. No obesity at the time of onset C. diabetic ketoacidosis onset D. Maximum random C-peptide <200 pmol/L
• Meet any one of the following criteria:
• A. Initiation and continuation of insulin therapy after diagnosis (excluding pancreas or islet transplantation) B. Positive for islet cell antibodies

Where it is running

• Department of Endocrinology and Metabolism, Peking University People's Hospital — Beijing, Beijing Municipality, China (enrolling)
• Department of Endocrinology, Beijing Tongren Hospital, Capital Medical University — Beijing, Beijing Municipality, China (enrolling)
• Department of Endocrinology and Metabolism, the Third Affiliated Hospital of Sun Yat-sen University — Guangzhou, Guangdong, China (enrolling)
• Department of Endocrinology, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University — Shenzhen, Guangdong, China (enrolling)
• Endocrinology and Metabolism Center, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology — Luoyang, Henan, China (enrolling)
• Institute of Metabolism and Endocrinology, Second Xiangya Hospital of Centra South University — Changsha, Hunan, China (enrolling)
• Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University — Nanjing, Jiangsu, China (enrolling)
• Department of Endocrinology and Metabolism, Institute of Endocrinology, The First Affiliated Hospital of China Medical University — Shenyang, Liaoning, China (enrolling)
• Department of Endocrinology and Metabolism, Laboratory of Diabetes and metabolism research, West China Hospital, Sichuan University — Chengdu, Sichuan, China (enrolling)
• Department of Endocrinology, Children's Hospital of Zhejiang University School of Medicine, National Clinical Research Center for Child Health — Hangzhou, Zhejiang, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.